iTonic Holdings (ITOC) Receivables Refunds (2023 - 2024)

iTonic Holdings recorded quarterly Receivables Refunds of $26477.0 in Q4 2024, down 5.88% quarter-over-quarter from $28131.0 in Q4 2023, and down 5.88% year-over-year from $28131.0 in Q1 2024.

iTonic Holdings' Receivables Refunds history runs 2 years deep, the most recent figure standing at $26477.0 for Q4 2024.

  • In Q4 2024, Receivables Refunds fell 5.88% year-over-year to $26477.0; the TTM figure through Dec 2024 stood at $26477.0 (down 5.88% YoY), while the FY2024 annual figure was $26477.0, down 5.88% from the prior year.
  • Receivables Refunds came in at $26477.0 for Q4 2024 at iTonic Holdings, down from $28131.0 in the prior quarter.
  • In the past five years, Receivables Refunds ranged from a high of $28131.0 in Q4 2023 to a low of $26477.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Refund Receivables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 52.68 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 iTonic Holdings 4.81 Mn 3.89 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 26,477.00
Dec 31, 2023 28,131.00